Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Muir-Torre syndrome

P R Cohen1, S R Kohn, D A Davis

  • 1Department of Dermatology, University of Texas-Houston Medical School, USA.

Dermatologic Clinics
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advanced basal cell cancer: concise review of molecular characteristics and novel targeted and immune therapeutics.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Advanced basal cell cancer: concise review of molecular characteristics and novel targeted and immune therapeutics.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer.

Oncogene·2016
Same author

Cultural considerations in the treatment of persons with AIDS.

Occupational therapy in health care·2013
Same author

The Ontario CME Survey: A Provider's Perspective.

Canadian family physician Medecin de famille canadien·2011
Same author

[Survey of continuing medical education in Ontario: the perspective of the provider].

Canadian family physician Medecin de famille canadien·2011
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Muir-Torre syndrome links sebaceous gland tumors to internal cancers. Early detection of skin lesions is crucial for identifying individuals at risk of developing associated visceral malignancies, particularly colorectal cancer.

Area of Science:

  • Oncology
  • Dermatology
  • Genetics

Background:

  • Muir-Torre syndrome is a rare autosomal dominant genodermatosis.
  • It is characterized by the co-occurrence of sebaceous gland tumors and internal malignancies.
  • This syndrome carries a significant malignant potential.

Purpose of the Study:

  • To highlight the association between sebaceous gland tumors and internal malignancies in Muir-Torre syndrome.
  • To emphasize the importance of screening for visceral cancers in affected individuals.
  • To inform clinicians about the diagnostic and management implications of Muir-Torre syndrome.

Main Methods:

  • Review of documented cases of Muir-Torre syndrome.
  • Analysis of associated cutaneous and visceral neoplasms.

Related Experiment Videos

  • Evaluation of tumor types and locations.

    • Main Results:

    • The syndrome has been documented in 147 individuals.
    • Colorectal carcinomas and genitourinary neoplasms are frequently associated.
    • Over half of the visceral cancers were colorectal, often proximal to the splenic flexure.

    Conclusions:

    • A single sebaceous gland tumor warrants evaluation for Muir-Torre syndrome.
    • Individuals with sebaceous tumors and Muir-Torre syndrome require screening for internal malignancies.
    • Family members should be screened for both cutaneous and visceral manifestations.